Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta

计划入组 2 人 · 首次发布于 2014 年 6 月 24 日

Cell Therapy for Diabetic Foot Ulcer

计划入组 60 人 · 首次发布于 2022 年 2 月 10 日

Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma

首次发布于 2013 年 1 月 17 日

CMB-100

human embryonic stem cell-based therapy (Jeil)

ex vivo Gp91phox-transduced autologous CD34+ hematopoietic stem cell therapy (ImmunoVec)

CytoMed Therapeutics

Singapore

Stem Cell Therapeutics Corp

Canada

Cell Therapy Ltd.

United Kingdom

Marcus Foundation awards $28.7 million to advance stem cell-based therapy for heart attack regeneration

Avant Technologies and SGAustria Launch Joint Venture to Develop Stem Cell-Based Diabetes Therapy

BOOST Pharma Advances Stem Cell Therapy BT-101 for Osteogenesis Imperfecta with Positive Two-Year Data and $4.4M Funding